BACKGROUND: This study aimed to evaluate the feasibility and safety of an innovative "all in one" integrated transseptal crossing device to achieve transseptal puncture (TSP). METHODS: Twenty patients (10 males, mean age 65.65 ± 9.25 years), indicated to supraventricular left side tachyarrhythmia ablation, underwent TSP using a new-generation integrated crossing device, and a control cohort of twenty patients (10 males, mean age 65.5 ± 10.12 years) underwent TSP using the traditional TSP system. RESULTS: In all the study patients, the novel TSP device led to a successful and safe access to the left atrium (LA). The mean transseptal time, defined as the time occurring between the groin puncture and the advancing of the guidewire into the left superior pulmonary vein (PV), was 3 min 33 s ± 44 s, 7 min 5 s ± 36 s in the control cohort. Additionally, we compared the cost of the two systems. No acute complications related to the TSP were noted in both cohorts. CONCLUSIONS: TSP performed with the new integrated transseptal system is feasible and safe.
BACKGROUND: This study aimed to evaluate the feasibility and safety of an innovative "all in one" integrated transseptal crossing device to achieve transseptal puncture (TSP). METHODS: Twenty patients (10 males, mean age 65.65 ± 9.25 years), indicated to supraventricular left side tachyarrhythmia ablation, underwent TSP using a new-generation integrated crossing device, and a control cohort of twenty patients (10 males, mean age 65.5 ± 10.12 years) underwent TSP using the traditional TSP system. RESULTS: In all the study patients, the novel TSP device led to a successful and safe access to the left atrium (LA). The mean transseptal time, defined as the time occurring between the groin puncture and the advancing of the guidewire into the left superior pulmonary vein (PV), was 3 min 33 s ± 44 s, 7 min 5 s ± 36 s in the control cohort. Additionally, we compared the cost of the two systems. No acute complications related to the TSP were noted in both cohorts. CONCLUSIONS: TSP performed with the new integrated transseptal system is feasible and safe.
Authors: Frank E Silvestry; Meryl S Cohen; Laurie B Armsby; Nitin J Burkule; Craig E Fleishman; Ziyad M Hijazi; Roberto M Lang; Jonathan J Rome; Yan Wang Journal: J Am Soc Echocardiogr Date: 2015-08 Impact factor: 5.251
Authors: Lucio Capulzini; Gaetano Paparella; Antonio Sorgente; Carlo de Asmundis; Gian Battista Chierchia; Andrea Sarkozy; Andreas Muller-Burri; Yoshinao Yazaki; Markus Roos; Pedro Brugada Journal: Europace Date: 2010-02-23 Impact factor: 5.214
Authors: Erwin Ströker; Yves De Greef; Bruno Schwagten; Kaspars Kupics; Hugo Enrique Coutiño; Ken Takarada; Juan Pablo Abugattas; Francesca Salghetti; Jeroen De Cocker; Dirk Stockman; Juan Sieira; Pedro Brugada; Gian-Battista Chierchia; Carlo de Asmundis Journal: Pacing Clin Electrophysiol Date: 2019-05-13 Impact factor: 1.976